Medscape Hematology-Oncology Headlines 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Few Childhood Cancer Survivors Get Recommended Screenings Few Childhood Cancer Survivors Get Recommended Screenings
Cancer survivors who were older at diagnosis were more likely to follow cancer screening guidelines, whereas those who were younger were more likely to get heart tests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 22, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
The Simple Change That Can Improve Patient Satisfaction The Simple Change That Can Improve Patient Satisfaction
Prof David Kerr discusses the importance of the physician ' s location when communicating with patients.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 22, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Diarrhea in Cancer Therapies — Part 1: Chemotherapeutics Diarrhea in Cancer Therapies — Part 1: Chemotherapeutics
A gastroenterologist and oncologist recently reviewed the appropriate assessment and treatment of patients with chemotherapy-associated diarrhea.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 22, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Predicting Risk for Secondary Leukemia after PARPi Therapy Predicting Risk for Secondary Leukemia after PARPi Therapy
A new study pinpointed potential predictive factors for secondary myelodysplastic syndrome or acute myeloid leukemia after PARP inhibitor therapy in women with ovarian cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 22, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Upfront Low-Dose Radiation Improves Advanced SCLC Outcomes Upfront Low-Dose Radiation Improves Advanced SCLC Outcomes
Researchers added low-dose radiation to standard first-line treatment for extensive-stage small cell lung cancer to extend treatment benefits.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 22, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
New CRC Risk Prediction Model Outperforms Polyp-Based Model New CRC Risk Prediction Model Outperforms Polyp-Based Model
A comprehensive model that includes additional risk factors beyond previous polyp findings showed improved post-colonoscopy risk stratification for colorectal cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 21, 2024 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news
CHIP: The Silent Threat Steps Into the Limelight CHIP: The Silent Threat Steps Into the Limelight
As CHIP is better understood, its cardiovascular and oncological risks are more clearly defined, along with what to do about them, say experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 21, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
New Transparent AI Predicts Breast Cancer 5 Years Out New Transparent AI Predicts Breast Cancer 5 Years Out
The model ' s easier-to-understand process marks an important milestone in the quest to bring AI to bedside in a meaningful way.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 21, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Myeloma: FDA Advisers Greenlight Early CAR-T Myeloma: FDA Advisers Greenlight Early CAR-T
An FDA advisory panel endorsed earlier use of CAR-T therapies to treat multiple myeloma but emphasized the importance of informing patients about potential risks associated with these treatments.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 21, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
FDA Approves Ponatinib for Upfront Ph+ ALL FDA Approves Ponatinib for Upfront Ph+ ALL
This is the first targeted treatment approved for upfront use in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 20, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Can ChatGPT Help Manage Gynecologic Cancers? Can ChatGPT Help Manage Gynecologic Cancers?
ChatGPT accurately answers common questions regarding gynecologic cancers but falls short in providing treatment recommendations, two separate studies found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 19, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
De-escalating Therapy for Oropharynx Squamous Cell Carcinoma De-escalating Therapy for Oropharynx Squamous Cell Carcinoma
Three new studies exploring treatment de-escalation of HPV-associated oropharynx squamous cell carcinoma added to data showing it ' s possible to reduce toxicity without jeopardizing oncologic outcomes.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 19, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
RUBY:'A Huge Win' for Patients With Endometrial Cancer RUBY:'A Huge Win' for Patients With Endometrial Cancer
The RUBY trial shows that adding an immune checkpoint inhibitor to chemotherapy improved overall survival by over 1 year for women with advanced or recurrent endometrial cancer.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 19, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
QOL Not Harmed With Add-On Pembrolizumab in Cervical Cancer QOL Not Harmed With Add-On Pembrolizumab in Cervical Cancer
Adding pembrolizumab to concurrent chemoradiotherapy does not affect quality of life in patients with high-risk locally advanced cervical cancer, new data show.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
EPA to Ban Last Form Of Asbestos Used in US EPA to Ban Last Form Of Asbestos Used in US
The U.S. Environmental Protection Agency on Monday finalized a rule that would ban using and importing cancer-causing asbestos, a material still used in some vehicles and in...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
